Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
EventHumanPharmacovigilance

Latvian is available via eTranslation, the European Commission's machine translation service.

Translate to Latvian | Important information about machine translation

Date

Pirmdiena, 5 Februāris 2024, Visu dienu
Ceturtdiena, 8 Februāris 2024, Visu dienu

Vieta

European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the PRAC meeting 5-8 February 2024

Draft Reference Number: EMA/PRAC/11237/2024 Corr.1

English (EN) (529.37 KB - PDF)

Pirmo reizi publicēts: Pēdējo reizi atjaunināts:
Skatīt

Minutes of the PRAC meeting 5-8 February 2024

Adopted Reference Number: EMA/PRAC/122241/2024

English (EN) (875.86 KB - PDF)

Pirmo reizi publicēts:
Skatīt

Share this page